SkyWater Technology to Announce Third Quarter Financial Results on November 8, 2023
BLOOMINGTON, Minn.–(BUSINESS WIRE)–SkyWater Technology (NASDAQ: SKYT), the trusted technology realization partner, today announced that it intends to... Read more.
Bupa UK to cover EpiSwitch® CiRT for customers with cancer
Bupa UK health insurance customers being considered for checkpoint inhibitor immunotherapy will now be offered the smart blood test, which accurately predicts a... Read more.
CIONIC Raises $12 Million Series A Extension Led by L Catterton with New Partners THVC and Enable Ventures
Nine months after the start of shipments, Cionic Neural Sleeve licensed nearly nationwide with more than 200,000 hours of customer use, transforming the lives of... Read more.
Crestwood Announces Extension of its Previously Announced Consent Solicitation
HOUSTON–(BUSINESS WIRE)–Crestwood Equity Partners LP (NYSE: CEQP) (“Crestwood”) today announced the extension of its previously announced solicitation... Read more.
CDW to Announce Third Quarter 2023 Results on November 1
VERNON HILLS, Ill.–(BUSINESS WIRE)–CDW Corporation (Nasdaq: CDW), a leading multi-brand provider of information technology solutions to business, government,... Read more.
D-Wave Showcases Advantage™ QPU’s Ability to Improve Cellphone Network Transmission
Open-source example highlights quantum’s potential to help network providers reduce operational costs and power requirements; reinforces practical applicability... Read more.
Park City Group to Transfer Listing to New York Stock Exchange, Trading Ticker: TRAK
New Ticker Symbol and Exchange Represents First Step in Corporate Rebranding SALT LAKE CITY–(BUSINESS WIRE)–Park City Group, Inc. (NASDAQ: PCYG), parent... Read more.
VillageMD Announces New Leadership Appointments for Three Services Lines – Summit Health, CityMD and Village Medical
CHICAGO & NEW YORK–(BUSINESS WIRE)–VillageMD announced today three new presidents to lead the three patient-facing services lines of Summit Health,... Read more.
Cessation Therapeutics Awarded $14.8 Million Grant from the National Institute of Drug Abuse to Develop Novel Formulation of Anti-Fentanyl Monoclonal Antibody
Grant will fund Investigational New Drug enabling studies and manufacturing for CSX-1004 SQ CHAPEL HILL, N.C.–(BUSINESS WIRE)–Cessation Therapeutics,... Read more.
Plasmid DNA Manufacturing Markets, 2035 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Plasmid DNA Manufacturing Market by Scale of Operation, Application Area, Therapeutic Area, and Geography: Industry... Read more.